Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan · Delayed Price · Currency is JPY 1,199.00
+12.00 (1.01%)
Jun 22, 2026, 3:30 PM JST
Daito Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
| 32,757 | 29,536 | 34,043 | 33,086 | 37,154 | 44,980 | |
Market Cap Growth | 9.24% | -13.24% | 2.89% | -10.95% | -17.40% | -21.02% |
Enterprise Value | 41,110 | 37,736 | 37,799 | 34,956 | 37,065 | 46,116 |
Last Close Price | 1187.00 | 953.97 | 1041.20 | 951.20 | 1055.36 | 1293.27 |
PE Ratio | 11.93 | 15.48 | 10.33 | 9.19 | 7.96 | 10.59 |
Forward PE | 13.16 | 15.15 | 8.98 | 9.39 | 8.00 | 10.05 |
PS Ratio | 0.65 | 0.58 | 0.73 | 0.73 | 0.86 | 0.92 |
PB Ratio | 0.63 | 0.57 | 0.65 | 0.65 | 0.78 | 1.07 |
P/TBV Ratio | 0.64 | 0.57 | 0.66 | 0.66 | 0.79 | 1.09 |
P/OCF Ratio | - | 5.01 | 6.57 | 7.96 | 8.50 | 8.68 |
EV/Sales Ratio | 0.81 | 0.75 | 0.81 | 0.78 | 0.85 | 0.95 |
EV/EBITDA Ratio | - | 5.43 | 5.00 | 3.85 | 3.75 | 5.08 |
EV/EBIT Ratio | 11.44 | 14.40 | 9.71 | 6.71 | 5.64 | 7.80 |
Debt / Equity Ratio | 0.19 | 0.23 | 0.17 | 0.10 | 0.07 | 0.08 |
Debt / EBITDA Ratio | - | 1.71 | 1.15 | 0.55 | 0.35 | 0.37 |
Net Debt / Equity Ratio | 0.16 | 0.19 | 0.12 | 0.03 | -0.02 | 0 |
Net Debt / EBITDA Ratio | - | 1.39 | 0.79 | 0.15 | -0.09 | 0.00 |
Net Debt / FCF Ratio | - | -10.85 | -5.77 | -1.00 | 3.63 | -0.02 |
Asset Turnover | 0.67 | 0.65 | 0.63 | 0.67 | 0.71 | 0.87 |
Inventory Turnover | 2.12 | 2.14 | 1.89 | 1.98 | 1.97 | 2.72 |
Quick Ratio | 1.26 | 1.32 | 1.05 | 1.38 | 1.46 | 1.26 |
Current Ratio | 2.50 | 2.45 | 2.24 | 2.64 | 2.70 | 2.52 |
Return on Equity (ROE) | 5.66% | 3.38% | 6.16% | 7.15% | 10.33% | 10.55% |
Return on Assets (ROA) | 2.89% | 2.10% | 3.28% | 4.81% | 6.69% | 6.60% |
Return on Invested Capital (ROIC) | 4.45% | 2.61% | 5.31% | 7.31% | 10.20% | 10.62% |
Return on Capital Employed (ROCE) | 5.90% | 4.30% | 6.60% | 9.50% | 12.90% | 13.20% |
Earnings Yield | 9.03% | 6.46% | 9.68% | 10.88% | 12.56% | 9.44% |
FCF Yield | - | -3.02% | -3.05% | -4.08% | -0.69% | -2.53% |
Dividend Yield | 3.37% | 3.67% | 2.88% | 2.87% | 2.15% | 1.62% |
Payout Ratio | - | 52.31% | 27.53% | 25.86% | 14.14% | 15.50% |
Buyback Yield / Dilution | 1.83% | 3.06% | 0.86% | -3.38% | -1.94% | -6.42% |
Total Shareholder Return | 5.20% | 6.73% | 3.75% | -0.52% | 0.21% | -4.80% |